Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 6/20 | 0.43 |
| ▸ | HTR3A | P46098 | 6/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11261432 | 0.83 | ALOX15 (0.48) | HSD17B10TP53MAPTMEN1KMT2A | |
| SCHEMBL3376143 | 0.81 | MAPT (0.46) | HSD17B10TP53MAPTMEN1KMT2A | |
| SCHEMBL576257 | 0.81 | NPC1 (0.50) | HSD17B10TP53MAPTMEN1KMT2A | |
| SCHEMBL29475022 | 0.81 | HAO1 (0.55) | HSD17B10TP53MAPTMEN1KMT2A | |
| SCHEMBL76793 | 0.81 | HAO1 (0.55) | HSD17B10TP53MAPTMEN1KMT2A | |
| SCHEMBL29411684 | 0.81 | NPC1 (0.50) | HSD17B10TP53MAPTMEN1KMT2A | |
| SCHEMBL12396605 | 0.78 | HPGD (0.51) | HSD17B10TP53MAPTMEN1KMT2A | |
| SCHEMBL11482988 | 0.77 | HAO1 (0.43) | HSD17B10TP53MAPTMEN1KMT2A | |
| SCHEMBL1145702 | 0.77 | HAO1 (0.43) | HSD17B10TP53MAPTMEN1KMT2A | |
| SCHEMBL13906344 | 0.77 | ALDH1A1 (0.43) | HSD17B10HPGDALDH1A1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230183481-A1 | A POLYPHENYLENE SULFIDE/POLYAMIDE COMPOSITION | BASF SE (DE) | 2023-06-15 | — | — | US | disclosed |
| US-20230144380-A1 | POLYMER HAVING EXCELLENT COMPATIBILITY WITH THERMOPLASTIC RESINS | TEIJIN LIMITED (JP) | 2023-05-11 | — | — | US | disclosed |
| WO-2023285136-A1 | THERMOPLASTIC MOLDING COMPOSITION WITH HIGH TEMPERATURE RESISTANCE COMPRISING A POLYPHENYLENE SULFIDE | BASF SE (DE) | 2023-01-19 | — | — | WO | disclosed |
| US-20220134323-A1 | CATALYST FOR HYDROGENATION REACTION AND METHOD FOR PRODUCING SAME | LG CHEM, LTD. (KR) | 2022-05-05 | — | — | US | disclosed |
| EP-3903934-A1 | CATALYST FOR HYDROGENATION REACTION AND METHOD FOR PRODUCING SAME | LG Chem, Ltd. (KR) | 2021-11-03 | — | — | EP | disclosed |
| WO-2019052935-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH (DE) | 2019-03-21 | — | — | WO | disclosed |
| WO-2019046784-A1 | COMPOUNDS AND METHODS FOR MODULATING ADENOSINE A2B RECEPTOR AND ADENOSINE A2A RECEPTOR | CORVUS PHARMACEUTICALS, INC. (US) | 2019-03-07 | — | — | WO | disclosed |
| US-9988521-B2 | Polyphenylene sulfide resin composition, production method thereof and reflector | TORAY INDUSTRIES, INC. (JP) | 2018-06-05 | — | — | US | disclosed |
| US-9957377-B2 | — | — | 2018-05-01 | — | — | US | disclosed |
| US-9790323-B2 | Polymer conductor for lithium-ion batteries | THE PENN STATE RESEARCH FOUNDATION (US) | 2017-10-17 | — | — | US | disclosed |
| WO-1999010357-A1 | BINUCLEAR NON-HEME IRON CATALYSTS | YALE UNIVERSITY (US) | 1999-03-04 | — | — | WO | disclosed |
| US-5840698-A | ENZYME INHIBITORS OF MERCAPTOKETONES AND MERCAPTOALCOHOLS FOR CONTROLLING DISEASES OF TISSUE BREAKDOWN, SKIN DISORDERS, ANTIINFLAMMATORY AGENTS OR ANTITUMOR AGENTS | AFFYMAX TECHNOLOGIES N.V. (GB) | 1998-11-24 | — | — | US | disclosed |
| US-5831004-A | Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use | AFFYMAX TECHNOLOGIES N.V. (GB) | 1998-11-03 | — | — | US | disclosed |
| EP-0832100-A4 | NOVEL INHIBITORS OF METALLOPROTEASES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AND METHODS OF THEIR USE | AFFYMAX TECH NV (AN) | 1998-09-02 | — | — | EP | disclosed |
| EP-0832100-A1 | NOVEL INHIBITORS OF METALLOPROTEASES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AND METHODS OF THEIR USE | AFFYMAX TECHNOLOGIES N.V. (AN) | 1998-04-01 | — | — | EP | disclosed |
| WO-1996040204-A1 | NOVEL INHIBITORS OF COLLAGENASE-1 AND STROMELYSIN-I METALLOPROTEASES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AND METHODS OF THEIR USE | AFFYMAX TECHNOLOGIES, N.V. (AN) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996040738-A1 | NOVEL INHIBITORS OF METALLOPROTEASES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AND METHODS OF THEIR USE | AFFYMAX TECHNOLOGIES, N.V. (AN) | 1996-12-19 | — | — | WO | disclosed |
| US-4289695-A | REACTION OF A PHENICILLIN WITH AN N-CHLORO HALOGENATING AGENT IN PRESENCE OF A CROSSLINKED POLYVINYLPYRIDINE | ELI LILLY AND COMPANY (US) | 1981-09-15 | — | — | US | disclosed |
| EP-0011370-A1 | Process for preparing 2-chlorosulfinyl-azetidinones | ELI LILLY AND COMPANY (US) | 1980-05-28 | — | — | EP | disclosed |
| US-4159272-A | Process for 2-chlorosulfinylazetidin-4-ones | ELI LILLY AND COMPANY (US) | 1979-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220134323-A1 | CATALYST FOR HYDROGENATION REACTION AND METHOD FOR PRODUCING SAME | GRHPR, HAO2, RAD51 | HSD17B10 230/4885TP53 3704/4885MAPT 3348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.